Gernot Riedel

Aberdeen, SCT AB252ZD, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications

Announcement of special issue: 'Behavioural pharmacology of ketamine and psychedelic drugs'.

Announcement of special issue: 'Behavioural pharmacology of ketamine and psychedelic drugs'.

Journal: Behavioural pharmacology
Published: March 25, 2026

Reproducible social phenotyping of 5xFAD mice in the Agora maze (Sociobox).

Reproducible social phenotyping of 5xFAD mice in the Agora maze (Sociobox).

Journal: Behavioural brain research
Published: February 25, 2026

The Icelandic Mutation in the Murine APP Gene, mAPPA673T, on Amyloid-β Plaque Burden in the 5×FAD Alzheimer Model.

The Icelandic Mutation in the Murine APP Gene, mAPPA673T, on Amyloid-β Plaque Burden in the 5×FAD Alzheimer Model.

Journal: Journal of integrative neuroscience
Published: November 26, 2025

Effect of the Icelandic Mutation APPA673T in the Murine APP Gene on Phenotype of Line 66 Tau Mice.

Effect of the Icelandic Mutation APPA673T in the Murine APP Gene on Phenotype of Line 66 Tau Mice.

Journal: Biomolecules
Published: November 22, 2025

Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model.

Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model.

Journal: Alzheimer's research & therapy
Published: September 03, 2025

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.

Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.

Journal: Journal of Alzheimer's disease : JAD
Published: August 01, 2025

Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease.

Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease.

Journal: Behavioural pharmacology
Published: June 23, 2025

Systematic gait analysis in alpha-synuclein transgenic line 62 mice using the CatWalk.

Systematic gait analysis in alpha-synuclein transgenic line 62 mice using the CatWalk.

Journal: Behavioural brain research
Published: May 27, 2025

Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain.

Hydromethylthionine sustains truncated tau-dependent inflammation-lowering effects in mouse brain.

Journal: The FEBS journal
Published: October 23, 2024

Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia.

Rivastigmine interferes with the pharmacological activity of hydromethylthionine on presynaptic proteins in the line 66 model of frontotemporal dementia.

Journal: Brain research bulletin
Published: October 15, 2024

PLB2Tau mice are impaired in novel and temporal object recognition and show corresponding traits in brain MRI.

PLB2Tau mice are impaired in novel and temporal object recognition and show corresponding traits in brain MRI.

Journal: Brain research bulletin
Published: August 18, 2024

Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine.

Mouse Exploratory Behaviour in the Open Field with and without NAT-1 EEG Device: Effects of MK801 and Scopolamine.

Journal: Biomolecules
Published: July 15, 2024
Showing 1-12 of 94

Last Updated: 09/26/2026